Find Puerarin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 3681-99-0, Kakonein, Daidzein-8-c-glucoside, 7-hydroxy-3-(4-hydroxyphenyl)-8-((2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)-4h-chromen-4-one, Puerarin 80 mm, Chebi:8633
Molecular Formula
C21H20O9
Molecular Weight
416.4  g/mol
InChI Key
HKEAFJYKMMKDOR-VPRICQMDSA-N
FDA UNII
Z9W8997416

Puerarin
puerarin is a natural product found in Neustanthus phaseoloides, Clematis hexapetala, and other organisms with data available.
1 2D Structure

Puerarin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
7-hydroxy-3-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one
2.1.2 InChI
InChI=1S/C21H20O9/c22-7-14-17(26)18(27)19(28)21(30-14)15-13(24)6-5-11-16(25)12(8-29-20(11)15)9-1-3-10(23)4-2-9/h1-6,8,14,17-19,21-24,26-28H,7H2/t14-,17-,18+,19-,21+/m1/s1
2.1.3 InChI Key
HKEAFJYKMMKDOR-VPRICQMDSA-N
2.1.4 Canonical SMILES
C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3C4C(C(C(C(O4)CO)O)O)O)O)O
2.1.5 Isomeric SMILES
C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O
2.2 Other Identifiers
2.2.1 UNII
Z9W8997416
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 7,4'-dihydroxyisoflavone-8beta-glucopyranoside

2. Kakonein

2.3.2 Depositor-Supplied Synonyms

1. 3681-99-0

2. Kakonein

3. Daidzein-8-c-glucoside

4. 7-hydroxy-3-(4-hydroxyphenyl)-8-((2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)-4h-chromen-4-one

5. Puerarin 80 Mm

6. Chebi:8633

7. Npi 031g

8. Daidzein 8-c-glucoside

9. Nsc-380711

10. 7-hydroxy-3-(4-hydroxyphenyl)-8-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one

11. Z9w8997416

12. Puerarin, Analytical Standard

13. Mfcd00063399

14. Ac1nqz4n

15. 8-c-glucoside

16. 8-glucosyldaidzein

17. Unii-z9w8997416

18. Kudzu Root Extract

19. Nsc 380711

20. 7,4'-dihydroxy-8-c-glucosylisoflavone

21. Brn 0064198

22. 8-glucopyranosyldaidzein

23. Puerarin [inci]

24. Puerarin [who-dd]

25. Surecn8581666

26. 4-19-00-03200 (beilstein Handbook Reference)

27. Mls002473178

28. Bidd:er0101

29. Chembl486386

30. Schembl8581666

31. Hkeafjykmmkdor-vpricqmdsa-

32. Dtxsid30958020

33. Hms2198m10

34. Puerarin, >=98.0% (hplc)

35. Hy-n0145

36. Zinc4098745

37. Bdbm50129558

38. 8-beta-d-glucopyranosyl-7-hydroxy-3-(4-hydroxyphenyl)-4h-1-benzopyran-4-one

39. Akos007930376

40. Akos015965556

41. Cs-6158

42. Db12290

43. Ks-5191

44. 4h-1-benzopyran-4-one, 8-beta-d-glucopyranosyl-7-hydroxy-3-(4-hydroxyphenyl)-

45. 7-hydroxy-3-(4-hydroxyphenyl)-8-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one

46. Ac-20294

47. Smr001397270

48. N1114

49. 4',7-dihydroxy-8-c-glucosylisoflavone

50. Q63408673

51. (1s)-1,5-anhydro-1-[7-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4h-chromen-8-yl]-d-glucitol

52. 4h-1-benzopyran-4-one, 8-.beta.-d-glucopyranosyl-7-hydroxy-3-(4-hydroxyphenyl)-

53. 8-(-bet.-d-glucopyranosyl-7-hydroxy-3- (4-hydroxyphenyl)-4h-1-benzopyran-4-one

54. 8-(beta-d-glucopyranosyl-7-hydroxy-3- (4-hydroxyphenyl)-4h-1-benzopyran-4-one

55. (1s)-1,5-anhydro-1-[7-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4h-1-benzopyran-8-yl]-d-glucitol

56. 7-hydroxy-3-(4-hydroxyphenyl)-8-[(3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 416.4 g/mol
Molecular Formula C21H20O9
XLogP30
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count9
Rotatable Bond Count3
Exact Mass416.11073221 g/mol
Monoisotopic Mass416.11073221 g/mol
Topological Polar Surface Area157 Ų
Heavy Atom Count30
Formal Charge0
Complexity659
Isotope Atom Count0
Defined Atom Stereocenter Count5
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Vasodilator Agents

Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)


Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty